As of 2024-12-13, the Relative Valuation of Cresco Labs Inc (CL.CN) is (16.33) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.42 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -1249.7%.
The range of the Relative Valuation is (15.12) - (16.29) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 31.5x | 30.4x |
| Forward P/E multiples | 27.8x - 30.0x | 29.7x |
| Fair Price | (15.12) - (16.29) | (16.33) |
| Upside | -1165.1% - -1247.0% | -1249.7% |
| Date | P/E |
| 2024-12-12 | -3.60 |
| 2024-12-11 | -3.70 |
| 2024-12-10 | -3.80 |
| 2024-12-09 | -3.96 |
| 2024-12-06 | -3.94 |
| 2024-12-05 | -4.01 |
| 2024-12-04 | -3.86 |
| 2024-12-03 | -4.01 |
| 2024-12-02 | -4.14 |
| 2024-11-29 | -4.30 |
| 2024-11-28 | -4.30 |
| 2024-11-27 | -4.48 |
| 2024-11-26 | -4.40 |
| 2024-11-25 | -4.35 |
| 2024-11-22 | -3.94 |
| 2024-11-21 | -4.20 |
| 2024-11-20 | -4.35 |
| 2024-11-19 | -4.40 |
| 2024-11-18 | -4.74 |
| 2024-11-15 | -5.13 |
| 2024-11-14 | -5.11 |
| 2024-11-13 | -5.24 |
| 2024-11-12 | -4.66 |
| 2024-11-11 | -3.86 |
| 2024-11-08 | -4.51 |
| 2024-11-07 | -4.56 |
| 2024-11-06 | -4.20 |
| 2024-11-05 | -5.45 |
| 2024-11-04 | -5.52 |
| 2024-11-01 | -5.58 |
| 2024-10-31 | -5.32 |
| 2024-10-30 | -5.37 |
| 2024-10-29 | -5.58 |
| 2024-10-28 | -5.73 |
| 2024-10-25 | -5.94 |
| 2024-10-24 | -5.89 |
| 2024-10-23 | -6.15 |
| 2024-10-22 | -6.07 |
| 2024-10-21 | -5.63 |
| 2024-10-18 | -5.68 |
| 2024-10-17 | -5.66 |
| 2024-10-16 | -5.60 |
| 2024-10-15 | -5.66 |
| 2024-10-11 | -5.73 |
| 2024-10-10 | -5.76 |
| 2024-10-09 | -5.86 |
| 2024-10-08 | -5.84 |
| 2024-10-07 | -5.81 |
| 2024-10-04 | -5.81 |
| 2024-10-03 | -5.86 |